Osteoarthritis study could lead to new treatments
More than 900 genetic links to osteoarthritis, including 500 which have never been reported, have been uncovered in a research study in Sheffield.
Sheffield Teaching Hospitals NHS Foundation Trust said the "landmark" global study into osteoarthritis was the largest of its kind.
The degenerative condition affects around 595 million people globally, and is the leading cause of disability and chronic pain worldwide, according to the hospital trust.
The genome study used genetic information from nearly two million people, and was published in the journal Nature.
Led by Helmholtz Munich, the largest scientific research organisation in Germany, genetic codes and DNA of almost half a million osteoarthritis sufferers globally - including 1,000 volunteers from Sheffield - were compared with that of 1.5 million people without the disease, the trust said.
The team identified 962 genetic variations more commonly found in those with osteoarthritis; more than 500 of which had not previously been identified, it said.
The number osteoarthritis sufferers was predicted to rise to a billion people by 2050 and despite the impact "no disease-modifying treatments are currently available", researchers said.
However the new work "paves the way for potential new drug treatments and personalised therapies," they continued.
Prof Mark Wilkinson, Honorary Consultant Orthopaedic Surgeon at the trust and the University of Sheffield, said the findings were "hugely important" and would "open up exciting new avenues" for millions.
"As well as identifying potential drug targets and opportunities for us to repurpose existing treatments that already target these genes in other conditions, this research has also significantly advanced our understanding of the underlying biological mechanisms associated with the disease," Prof Wilkinson said.
Eight biological processes which regulate the body's internal systems and cell function were found, "shedding light on the disease's biological mechanisms", the trust said.
Some of these genes contain proteins already targeted by drugs approved for other conditions, which could accelerate treatment development, it added.
Listen to highlights from South Yorkshire on BBC Sounds, catch up with the latest episode of Look North.
Sheffield Teaching Hospitals NHS Foundation Trust
NHS: Osteoarthritis
Nature
Exercise to treat arthritis, new advice suggests
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 hours ago
- Yahoo
New facility will 'offer lifeline to SEND pupils'
A facility has opened to help support pupils with Special Educational Needs and Disabilities (SEND). Based at Francis Askew Primary School in Hull, it will be used by Rise Academy and will accommodate up to 25 pupils aged 11 to 16, according to the city council. The Constellation Trust, which runs the academy, said the facility was set to transform opportunities for some of the region's most vulnerable learners. According to the city council, the site would enable the school to meet the growing demand for SEND places in the area and "offer a lifeline to children who have struggled to thrive in mainstream settings". The site, which includes four classrooms, a science room, sensory room, parents' room and an extended dining area, would allow staff to better understand those that have had a difficult start and to help them flourish, the school added. The project is an expansion of Rising Stars, part of Rise Academy, primarily for students with cognition, learning, speech, language and communication needs. They may also have sensory, or other physical impairments or disabilities. Councillor Linda Tock, portfolio holder for children's services at the council, said: "Witnessing the children in this environment and how much it is benefitting them is fantastic to see. "The enthusiasm and passion from both staff and students shone throughout our visit." Philip Mountain Wade, project lead and executive head of alternative curriculum for the trust, said the council's investment had allowed them to focus on designing a learning environment that would nurture emotional wellbeing, build resilience and unlock potential. Dr Cathy Taylor, CEO of the trust, added: "This is not just about a building, it's about creating a place where children can find safety, rebuild confidence and feel hope for the future." The project, which refurbished and repurposed a disused area of an existing building, was backed by the council's Children, Young People and Family Services' High Needs fund. Work began in December 2024 and was completed in spring. Listen to highlights from Hull and East Yorkshire on BBC Sounds, watch the latest episode of Look North or tell us about a story you think we should be covering here. Hospital launches animated video for SEND children Special school plans extension to boost places Hull City Council
Yahoo
17 hours ago
- Yahoo
'Employers should take a chance on unpaid carers'
A woman who gave up her job to look after her autistic child has urged employers to be more accommodating and open-minded towards unpaid carers. Elizabeth Dew, from Sheffield, said she had to quit her full time position in 2014, two years after the birth of her son. Now working again part-time she said she wanted to "challenge the misconception that a carer is going to be a burden on the workplace". She spoke as new research by the University of Sheffield suggested there were more than five million unpaid carers in England and Wales. Ms Dew said she had hoped to "pick her career up again" sooner, but her son's needs became more demanding over time. She said she claimed Universal Credit to "top up" her income, but it "barely" covered their needs. "There's no recognition that I'm doing the work that someone else isn't doing - it's unpaid and unrecognised work," she said. "I don't begrudge my children, but it would be really great to have a recognition that it's more than your average parent and I've missed out on earning as much as I potentially could be." According to the university's Centre for Care unpaid carers are providing more hours of care than ever before. It said the number of carers who provided 50 hours of unpaid care per week had increased from 24% to 30% between 2011 and 2021 - equivalent to £162bn of care a year. As part of Carers Week, the centre launched a digital dashboard to compare data on unpaid carers collected by the Office for National Statistics in England and Wales. Ms Dew said she would like to see "more flexibility in the workplace" for carers and a statutory right to paid carer's leave, having previously had to take unpaid leave she "couldn't afford". She added carers are "often fantastic employees". "We have so much experience from juggling all kinds of different situations, and we can often be excellent at problem solving and time management," she said. A government spokesperson said: "We recognise the immense contribution of carers who selflessly dedicate their time to supporting others. "We want families to receive the support they deserve which is why we have increased the Carer's Allowance earnings threshold by around an additional £2,000 a year – the biggest rise since it was introduced in 1976. "We have also launched an independent review into social care, which will include exploring the needs of unpaid carers who provide vital care and support." Listen to highlights from South Yorkshire on BBC Sounds or catch up with the latest episode of Look North. 'I look after my grandson but don't get carer's allowance' 'I slowly realised I was running two households' I love dad to bits - but being his carer has broken me Mum told to 'give up' career to care for daughters University of Sheffield Carers Week
Business Wire
20 hours ago
- Business Wire
Taconic Biosciences Enters Into an Exclusive License Agreement With Helmholtz Munich to Expand Its CRISPR/Cas9 Gene Editing Services
RENSSELAER, N.Y.--(BUSINESS WIRE)-- Taconic Biosciences, a global leader in providing animal model solutions and services, entered into an exclusive license agreement with Helmholtz Munich, one of Germany's leading biomedical research centers, to provide preclinical researchers with advanced CRISPR gene editing services. By exclusively licensing Helmholtz Munich's groundbreaking gene editing techniques and applications, Taconic Biosciences strengthens its position as a leader in the commercialization of cutting-edge CRISPR gene editing services. Share Through this agreement, Taconic has acquired the exclusive rights to a patented CRISPR-based gene editing technology developed at Helmholtz Munich to improve the generation of genetically modified animal models for biomedical research. "Taconic is excited to expand our already extensive capabilities in CRISPR/Cas9 gene editing through this new partnership with Helmholtz Munich,' said Mike Garrett, Chief Executive Officer of Taconic Biosciences. 'This technology significantly enhances Taconic's ExpressMODEL ® platform to deliver high-quality, precise CRISPR/Cas9-generated custom animal models on an accelerated timeline to our customers." Taconic has been a pioneer in CRISPR/Cas9 gene editing services for over a decade and remains at the forefront of advanced gene-modification methodologies. By exclusively licensing Helmholtz Munich's groundbreaking gene editing techniques and applications, Taconic Biosciences strengthens its position as a leader in the commercialization of cutting-edge CRISPR gene editing services. "This agreement with Taconic will deepen our understanding of gene function by enabling the development of advanced, genetically engineered animal models," said Prof. Dr. Wolfgang Wurst, co-inventor of the licensed technology at Helmholtz Munich. "By combining our innovative CRISPR technology with Taconic's expertise in animal model generation and breeding, we aim to accelerate the creation of precise models that uncover the genetic basis of diseases — supporting scientific discovery and paving the way for future medical breakthroughs.' This partnership marks a significant milestone in Taconic's commitment to providing researchers with advanced tools for biomedical research. By integrating novel CRISPR/Cas9 technologies with proven expertise in model generation, the collaboration supports the rapid development of scientific breakthroughs and improved translation of genetic research into therapeutic innovation. To learn more about the ExpressMODEL ® CRISPR Platform and our Custom Model Generation Solutions, visit Or call 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe, or email info@ About Taconic Biosciences, Inc. Taconic Biosciences is a fully licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions enabling customers to acquire, custom-generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, microbiome, immuno-oncology mouse models, and integrated model design and breeding services, Taconic operates service laboratories and breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.
